<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04675840</url>
  </required_header>
  <id_info>
    <org_study_id>KarlstadCH</org_study_id>
    <nct_id>NCT04675840</nct_id>
  </id_info>
  <brief_title>Intrathecal Morphine for Robotic-assisted Laparoscopic Hysterectomy.</brief_title>
  <official_title>Intrathecal Morphine for Robotic-assisted Laparoscopic Hysterectomy- a Prospective Randomized Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karlstad Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karlstad Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Is there any difference in the intensity of postoperative pain, nausea, urinary retention and&#xD;
      legth of hospital stay in patients undergoing robotic assisted laparoscopic surgery if they&#xD;
      receive intrathecal morphine or peroral and intravenous opiates during the surgery and is&#xD;
      there a significant difference in the need of opiates after the surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postop morphine consumption</measure>
    <time_frame>First 48 hours after surgery</time_frame>
    <description>Amount of opiates given postop</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postop grade of nausea &amp; vomiting</measure>
    <time_frame>First 24 hours after surgery</time_frame>
    <description>Amount of antemetics given</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay.</measure>
    <time_frame>Up to 7 days</time_frame>
    <description>Time from surgery (day 0) until Fit For Discharge FFD, defined as: 1) is taking oral pain medication only; 2) is able to walk around independently; 3) is tolerating full oral diet and have bowel movements; 4) is hemodynamically an respiratory stable; 5) has no drains or urinary catheter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient overall satisfaction score.</measure>
    <time_frame>Up to 7 days.</time_frame>
    <description>1-10, where 1 is unsatisfied and 10 is very satisfied.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Opioid-Related Disorders</condition>
  <arm_group>
    <arm_group_label>intrathecal morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spinal injection of 15mg Bupivakain and 0,25mg morphine before surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>opiate po/iv</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient given 10mg Oxycodone orally before surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Robotic-assisted hysterectomy</intervention_name>
    <description>Robotic-assisted surgery</description>
    <arm_group_label>intrathecal morphine</arm_group_label>
    <arm_group_label>opiate po/iv</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        * Patients accepted for robotic-assisted laparoscopic surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Coagulopathy,&#xD;
&#xD;
          -  Prior spine surgery,&#xD;
&#xD;
          -  Chronic pain problems,&#xD;
&#xD;
          -  Drug abuse,&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  &lt; 18 years&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Hysterectomy</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ragnar N Henningsson, Associate Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dpt of Anesthesiology &amp; Intensive Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ragnar N Henningsson, Associate Professor</last_name>
    <phone>+46708707524</phone>
    <email>ragnar.henningsson@regionvarmland.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesia &amp; Intensive Care</name>
      <address>
        <city>Karlstad</city>
        <state>Värmland</state>
        <zip>65181</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ragnar N Henningsson, Associate Professor</last_name>
      <phone>+46708707524</phone>
      <email>ragnar.henningsson@regionvarmland.se</email>
    </contact>
    <contact_backup>
      <last_name>Anders Engström, MD</last_name>
      <phone>+4654615000</phone>
      <email>anders.engstrom@regionvarmland.se</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 11, 2020</study_first_submitted>
  <study_first_submitted_qc>December 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2020</study_first_posted>
  <last_update_submitted>December 14, 2020</last_update_submitted>
  <last_update_submitted_qc>December 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karlstad Central Hospital</investigator_affiliation>
    <investigator_full_name>Ragnar Henningsson</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Opioid-Related Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

